Jaguar Health
Jaguar Health is committed to discovering, developing, and commercializing plant-based prescription medicines for urgent global health needs. They focus on sustainable harvesting and community benefit sharing, leveraging their broad intellectual property portfolio and botanical library to address unmet medical needs worldwide. The company is actively involved in pipeline development for human and animal health, with a focus on gastrointestinal distress and rare diseases, and is engaged in research initiatives including entheogen therapeutics for mental health.
Industries
Nr. of Employees
small (1-50)
Jaguar Health
San Francisco, California, United States, North America
Products
Commercial-stage oral botanical prescription therapeutic (human)
A commercial-stage oral botanical prescription medicine indicated for symptomatic relief of chronic noninfectious diarrhea in adults in a specific clinical context.
Clinical-stage antisecretory agent for infectious diarrhea
A second-generation antisecretory compound in development for symptomatic relief of infectious diarrheal illnesses, with IND activation and IND-enabling preclinical toxicology studies supported.
Botanical active pharmaceutical ingredient used across human and veterinary programs
A plant-derived active compound developed as an API and evaluated in approved and investigational programs for multiple gastrointestinal indications in humans and animals.
Conditionally approved veterinary gastrointestinal therapeutic
A veterinary gastrointestinal product that received conditional market approval in the United States and is under further development for additional companion‑animal indications.
Commercial-stage oral botanical prescription therapeutic (human)
A commercial-stage oral botanical prescription medicine indicated for symptomatic relief of chronic noninfectious diarrhea in adults in a specific clinical context.
Clinical-stage antisecretory agent for infectious diarrhea
A second-generation antisecretory compound in development for symptomatic relief of infectious diarrheal illnesses, with IND activation and IND-enabling preclinical toxicology studies supported.
Botanical active pharmaceutical ingredient used across human and veterinary programs
A plant-derived active compound developed as an API and evaluated in approved and investigational programs for multiple gastrointestinal indications in humans and animals.
Conditionally approved veterinary gastrointestinal therapeutic
A veterinary gastrointestinal product that received conditional market approval in the United States and is under further development for additional companion‑animal indications.
Services
Clinical development and trial support
Design, execution, and operational support for investigator-initiated and sponsor‑led clinical trials across phases, including multiregional coordination.
Regulatory affairs and submission support
Preparation and management of regulatory filings and strategies, including IND activation, orphan-drug designation pursuit, and planning for conditional marketing authorization pathways.
Manufacturing process development for botanical compounds
Process design and scale-up for production of botanical active ingredients and formulations, with capability to transfer to partner manufacturing.
Sustainable sourcing and community partnership programs
Field programs to implement sustainable harvest, replanting, and fair-benefit partnerships that secure botanical raw materials while supporting local communities.
Business development and partnering support
Advisory and partnering services to identify licensing, alliance, and commercialization opportunities and to support advisory-committee driven decision making.
Clinical development and trial support
Design, execution, and operational support for investigator-initiated and sponsor‑led clinical trials across phases, including multiregional coordination.
Regulatory affairs and submission support
Preparation and management of regulatory filings and strategies, including IND activation, orphan-drug designation pursuit, and planning for conditional marketing authorization pathways.
Manufacturing process development for botanical compounds
Process design and scale-up for production of botanical active ingredients and formulations, with capability to transfer to partner manufacturing.
Sustainable sourcing and community partnership programs
Field programs to implement sustainable harvest, replanting, and fair-benefit partnerships that secure botanical raw materials while supporting local communities.
Business development and partnering support
Advisory and partnering services to identify licensing, alliance, and commercialization opportunities and to support advisory-committee driven decision making.
Expertise Areas
- Clinical trial management for multi-phase programs
- Botanical drug discovery and development
- Ethnobotanical research and botanical library screening
- Manufacturing scale-up for botanical active ingredients
Key Technologies
- Botanical extraction and purification techniques
- High-throughput screening of plant extracts
- Ion-channel modulation as an antisecretory therapeutic mechanism
- In vitro functional assays for GI activity